Alcresta Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
130 Turner St Bldg 3 Ste 200, Waltham, M...Website
www.alcresta.comRevenue
$21.6 MillionIndustry
About Alcresta Therapeutics
Alcresta Therapeutics specializes in enzyme-based products aimed at improving enteral nutrition for patients suffering from fat malabsorption due to rare diseases. Their flagship product, RELiZORB, is a digestive enzyme cartridge designed to enhance fat digestion for individuals on enteral feeding, particularly those with conditions like cystic fibrosis and pancreatitis. The company targets patients who require enteral nutrition at home or in clinical settings, focusing on improving health outcomes through better nutrient absorption. Alcresta is committed to advancing clinical research and providing innovative solutions for patients with serious medical conditions.Explore more
Alcresta Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alcresta Therapeutics
Compare insights from companies similar to Alcresta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$21.9M
51-200
Private
-
1992
ML
Michael LyttonGroup Executive VP-Corp Development and Strategy and Gen Manager
Alcresta Therapeutics Tech Stack
A closer look at the technologies used by Alcresta Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alcresta Therapeutics
Sign Up For FreeTo access detailed company insights
Alcresta Therapeutics specializes in enzyme-based products aimed at improving enteral nutrition for patients suffering from fat malabsorption due to rare diseases. Their flagship product, RELiZORB, is a digestive enzyme cartridge designed to enhance fat digestion for individuals on enteral feeding, particularly those with conditions like cystic fib... Read More
